Clinical Trial Update: A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia [Phase 2]

View source ↗

Summary

Phase 2 study to assess the efficacy and safety of luspatercept in adults with alpha-thalassemia, with safety and pharmacokinetics in adolescents; recruitment i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-thalassemia
• Anemia

Drugs mentioned

• Luspatercept (luspatercept)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Anemia | Phase 2 | Status: RECRUITING